MedCity News

Trilliant Health: Misaligned Incentives Are Undermining US Healthcare

Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform

Teladoc Health announced Wednesday that it is launching two new AI-powered capabilities built into its Solo smart care platform for hospitals and health systems to be used during virtual visits.

By Jenna Congdon

BioPharma, Pharma

Caribou Bio’s Journey With Off-the-Shelf Cell Therapy Reaches the End of the Road

Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the business. The move follows the CRISPR biotech company’s failure to secure financing for its clinical trial plans.

By Frank Vinluan

MedCity Influencers

close-up studio macro shot of various pills on US dollar bills.

PBM Transparency Is Still Too Opaque — How Can Employers Rein In Drug Costs?

Employers are trying to comparison shop in a market where all the price tags are hidden. And most can’t simply switch PBMs to find better pricing for their members.

By Christine Johnston

Latest Video

Latest News

MedCity Influencers

From Distributor to Disruptor: Amazon’s Healthcare Flex

No longer satisfied with buying pharmacies and clinics, it seems intent on owning the healthcare journey, and perhaps redrawing pharma’s commercialization map.

By Adrienne Lovink

Providers

Cybersecurity Experts to Hospital Leaders: Think Beyond Traditional Disaster-Recovery Planning

Cybersecurity leaders discussed how AI-driven cybersecurity attacks pose a new level of risk for hospitals and health systems at Rubrik's Healthcare Summit last week.

By Jenna Congdon

Providers, Policy

FTC Sends Warning Letters to 24 Healthcare Organizations Over Price Transparency

The FTC sent warning letters to 24 major healthcare organizations over concerns about inadequate price transparency.

By Marissa Plescia

BioPharma, Startups

Forbion Bucks VC Fundraising Trends, Reeling In €2.3B for Two New Funds

Forbion’s new capital will support two funds that will invest in about 30 companies combined. The new funds for Netherlands-based Forbion come amid a decline in VC fundraising and investments in Europe, according to Pitchbook.

By Frank Vinluan

MedCity Influencers

Why Pharma Companies Should Look To Social Media For Better Patient Insight

Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.

By Rohit Marwah

MedCity Influencers

Perimenopause Anxiety: Sometimes It’s a Progesterone Deficiency

Perimenopausal anxiety isn't simply in our patients' heads. It's often the result of complex physiologic changes involving hormones, sleep, metabolism, and the nervous system.

By Lexi Yoo

MedCity Influencers

MedTech VC 2026: The Real Story vs. The Thesis

I kept hearing “medtech VC is in decline,” so I decided to dig into the data myself. I expected shrinking investor interest, inflated valuations, and a weak exit environment. Instead, I found a more nuanced story.

By Jordan Lisnow

Hidden Risks and Costs of Maternal/Infant Health that Health Plans Miss

A new report from ProgenyHealth offers a window into how the business works with commercial and Medicaid plans to close gaps in maternity and NICU care management that traditional programs overlook.

By Stephanie Baum

Health Tech

Investing in Community Health: A New Model for Safety-Net Healthcare Innovation

Launched last week, Facktor Ventures, an early-stage venture fund is taking a new approach to healthcare investing: they’re structured so that the organizations delivering care on the ground collectively become majority owners of the fund as limited partners.

By Jenna Congdon

BioPharma, Pharma

Shionogi Adds to Its Rare Disease Strategy With $2B IntraBio Acquisition

Shionogi’s IntraBio acquisition brings Aqneursa, a drug approved for treating two rare neurological disorders and the potential to expand to additional indications, both rare and common. It’s Shionogi’s second big rare disease move this year, following the acquisition of global rights to an amyotrophic lateral sclerosis drug from Tanabe Pharma.

By Frank Vinluan

Policy, Payers

Little pink ceramic piggy bank pattern on the left side on yellow background. Concept of saving money, savings.

Trump Administration Announces $90 Payments to Help Cover Medicare Part B Premiums

The Trump administration is issuing one-time $90 payments to more than 20 million Medicare beneficiaries to help cover Part B premiums, though the payments may do little to offset rising healthcare costs.

By Marissa Plescia

MedCity Influencers

A receptionist in a doctor's office hands paperwork to a patient over the counter. The office is bright and modern, providing a welcoming atmosphere.

The Biggest Healthcare Fix Might Not Come From a Vendor

Nobody has ever needed convincing on what to fix. What they've lacked is a way to act on it themselves, in something close to real time instead of on a vendor's roadmap.

By Ryan Hungate

BioPharma, Startups

Immunology Startup ai3Bio Aims to Redefine What It Means to Reset the Immune System

While the immune reset field is mainly focused on depleting pathogenic B cells, ai3Bio is applying its novel approach to inflammatory T cells. The startup’s initial disease targets are autoimmune disorders of the liver that have few treatment options if any at all.

By Frank Vinluan

Policy

Trump’s ACA Fraud Crackdown: Experts Urge Going After Bad Actors, Not Patients

The Trump administration’s ACA fraud crackdown will remove 760,000 people from Marketplace coverage, drawing criticism from healthcare experts and advocates.

By Marissa Plescia